Veracyte Inc.
VCYT | NASDAQ
$43.05
+$1.53 (+3.68%)
Sep 22, 2026, 1:17 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | 50.12 | 123.75 | -26.97 | -46.53 | -37.12 | -74.15 |
PEG Ratio | 0.31 | -0.94 | -0.27 | 0.86 | -0.54 | -0.51 |
PS Ratio | 6.40 | 6.79 | 5.54 | 5.73 | 12.74 | 22.18 |
PB Ratio | 2.53 | 2.58 | 1.91 | 1.58 | 2.55 | 6.19 |
P/FCF Ratio | 26.13 | 47.47 | 58.33 | -1.67K | -75.60 | -207.64 |
P/OCF Ratio | 24.27 | 40.33 | 45.19 | 225.33 | -88.46 | -268.31 |
OCF/S Ratio | 26.36 | 16.85 | 12.25 | 2.54 | -14.40 | -8.27 |
Debt / Equity Ratio | 0.03 | 0.04 | 0.01 | 0.01 | 0.02 | 0.03 |
Quick Ratio | 7.81 | 4.46 | 4.40 | 3.74 | 3.61 | 22.11 |
Current Ratio | 8.15 | 4.73 | 4.66 | 3.97 | 3.79 | 22.39 |
Asset Turnover | 0.37 | 0.34 | 0.32 | 0.26 | 0.18 | 0.26 |
Interest Coverage | n/a | 8.07K | -5.72K | -207.48 | -339.85 | -154.54 |
Return on Equity | 5.07% | 2.05% | -7.13% | -3.40% | -6.89% | -8.29% |
Return on Assets | 4.72% | 1.86% | -6.67% | -3.16% | -6.36% | -7.64% |
Return on Invested Capital | 5.34% | 1.23% | -7.87% | -3.74% | -6.72% | -8.01% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 69.62% | 66.88% | 68.73% | 65.74% | 66.11% | 64.71% |
Net Profit Margin | 12.83% | 5.42% | -20.61% | -12.33% | -34.42% | -29.71% |
Pretax Profit Margin | 13.19% | 5.78% | -21.22% | -12.28% | -37.20% | -29.71% |
Operating Profit Margin | 14.34% | 3.62% | -23.76% | -13.85% | -37.31% | -30.12% |
FCF Margin | 24.49% | 14.31% | 9.49% | -0.34% | -16.85% | -10.68% |
EBITDA Margin | 17.33% | 11.04% | -13.68% | -2.35% | -27.42% | -22.76% |
Add to Watchlist
Select watchlists to add or remove VCYT